Next Article in Journal
Novel Cell-Based and Tissue Engineering Approaches for Induction of Angiogenesis as an Alternative Therapy for Diabetic Retinopathy
Previous Article in Journal
The Neuropeptide System and Colorectal Cancer Liver Metastases: Mechanisms and Management
Previous Article in Special Issue
Particulate Air Pollution, Clock Gene Methylation, and Stroke: Effects on Stroke Severity and Disability
Open AccessReview

Inhalation Toxicology of Vaping Products and Implications for Pulmonary Health

1
Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada
2
Department of Medicine, McGill University, Montreal, QC H4A 3J1, Canada
3
Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montreal, QC H4A 3J1, Canada
4
Department of Pathology, McGill University, Montreal, QC H3A 2B4, Canada
5
Department of Pharmacology and Therapeutics, McGill University, Montreal, QC H3G 1Y6, Canada
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(10), 3495; https://doi.org/10.3390/ijms21103495
Received: 26 March 2020 / Revised: 28 April 2020 / Accepted: 12 May 2020 / Published: 15 May 2020
(This article belongs to the Special Issue Inhalation Toxicology and Biological Response)
E-cigarettes have a liquid that may contain flavors, solvents, and nicotine. Heating this liquid generates an aerosol that is inhaled into the lungs in a process commonly referred to as vaping. E-cigarette devices can also contain cannabis-based products including tetrahydrocannabinol (THC), the psychoactive component of cannabis (marijuana). E-cigarette use has rapidly increased among current and former smokers as well as youth who have never smoked. The long-term health effects are unknown, and emerging preclinical and clinical studies suggest that e-cigarettes may not be harmless and can cause cellular alterations analogous to traditional tobacco smoke. Here, we review the historical context and the components of e-cigarettes and discuss toxicological similarities and differences between cigarette smoke and e-cigarette aerosol, with specific reference to adverse respiratory outcomes. Finally, we outline possible clinical disorders associated with vaping on pulmonary health and the recent escalation of acute lung injuries, which led to the declaration of the vaping product use-associated lung injury (EVALI) outbreak. It is clear there is much about vaping that is not understood. Consequently, until more is known about the health effects of vaping, individual factors that need to be taken into consideration include age, current and prior use of combustible tobacco products, and whether the user has preexisting lung conditions such as asthma and chronic obstructive pulmonary disease (COPD). View Full-Text
Keywords: e-cigarettes; cannabis; vaping; respiratory; inflammation; cannabinoid; lung injury; EVALI; lipoid pneumonia; vitamin E acetate e-cigarettes; cannabis; vaping; respiratory; inflammation; cannabinoid; lung injury; EVALI; lipoid pneumonia; vitamin E acetate
Show Figures

Graphical abstract

MDPI and ACS Style

Traboulsi, H.; Cherian, M.; Abou Rjeili, M.; Preteroti, M.; Bourbeau, J.; Smith, B.M.; Eidelman, D.H.; Baglole, C.J. Inhalation Toxicology of Vaping Products and Implications for Pulmonary Health. Int. J. Mol. Sci. 2020, 21, 3495.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop